Literature DB >> 12176142

Use of heat labile UNG in an RT-PCR assay for enterovirus detection.

Edward W Taggart1, Karen C Carroll, Carrie L Byington, Gwen A Crist, David R Hillyard.   

Abstract

A reverse transcription-polymerase chain reaction (RT-PCR) assay was developed to replace the Roche AMPLICOR Enterovirus Test used in our laboratory from 1996 to 1999. The new assay design was optimized to match or exceed the performance of the Roche AMPLICOR Enterovirus test kit with respect to analytical sensitivity and specificity, contamination control, ease of use and availability of reagents. This new assay uses a heat labile form of the enzyme uracil DNA glycosylase (UNG) for amplicon contamination control and an RT-PCR enzyme mixture, enabling a one tube/one step amplification. RNA preparation was undertaken using a commercial extraction kit. End detection was accomplished using a probe-capture enzyme immuno assay (EIA) plate format. This EV RT-PCR assay exceeds the performance of the Roche AMPLICOR Enterovirus assay in a direct comparison. The combined enzymological approach has potential application to a wide variety of assays requiring sensitive RNA detection and stringent contamination control, including those utilizing real time detection methods.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176142     DOI: 10.1016/s0166-0934(02)00080-0

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  2 in total

1.  Quantitative assessment of the effect of uracil-DNA glycosylase on amplicon DNA degradation and RNA amplification in reverse transcription-PCR.

Authors:  Steven B Kleiboeker
Journal:  Virol J       Date:  2005-04-11       Impact factor: 4.099

2.  Rapid identification of health care-associated infections with an integrated fluorescence anisotropy system.

Authors:  Ki Soo Park; Chen-Han Huang; Kyungheon Lee; Yeong-Eun Yoo; Cesar M Castro; Ralph Weissleder; Hakho Lee
Journal:  Sci Adv       Date:  2016-05-06       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.